Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-10-002504
Filing Date
2010-01-08
Accepted
2010-01-08 16:29:21
Documents
1
Period of Report
2010-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8722
  Complete submission text file 0001209191-10-002504.txt   10604
Mailing Address 400 OYSTER POINT BOULEVARD, SUITE 502 SOUTH SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BOULEVARD, SUITE 502 -- SOUTH SAN FRANCISCO CA 94080 6506249600
ANESIVA, INC. (Issuer) CIK: 0001131517 (see all company filings)

EIN.: 770503399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111
Business Address
JANNEY DANIEL (Reporting) CIK: 0001198325 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50573 | Film No.: 10517959